CY784A - Process for purifying cephaloglycin antibiotic and the antibiotic thus obtained - Google Patents

Process for purifying cephaloglycin antibiotic and the antibiotic thus obtained

Info

Publication number
CY784A
CY784A CY784A CY78469A CY784A CY 784 A CY784 A CY 784A CY 784 A CY784 A CY 784A CY 78469 A CY78469 A CY 78469A CY 784 A CY784 A CY 784A
Authority
CY
Cyprus
Prior art keywords
antibiotic
cephaloglycin
purifying
purifying cephaloglycin
cephaloglycin antibiotic
Prior art date
Application number
CY784A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY784A publication Critical patent/CY784A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
CY784A 1969-02-17 1969-11-19 Process for purifying cephaloglycin antibiotic and the antibiotic thus obtained CY784A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79999169A 1969-02-17 1969-02-17

Publications (1)

Publication Number Publication Date
CY784A true CY784A (en) 1976-06-01

Family

ID=25177238

Family Applications (1)

Application Number Title Priority Date Filing Date
CY784A CY784A (en) 1969-02-17 1969-11-19 Process for purifying cephaloglycin antibiotic and the antibiotic thus obtained

Country Status (17)

Country Link
US (1) US3496171A (en)
AT (1) AT293618B (en)
BE (1) BE742086A (en)
BR (1) BR6914264D0 (en)
CH (1) CH531006A (en)
CS (1) CS157076B2 (en)
CY (1) CY784A (en)
DE (1) DE1958329C3 (en)
ES (1) ES373868A1 (en)
FR (1) FR2031460B1 (en)
GB (1) GB1254148A (en)
IE (1) IE33619B1 (en)
IL (1) IL33326A (en)
MY (1) MY7500052A (en)
NL (1) NL6917696A (en)
PL (1) PL83176B1 (en)
SE (1) SE372536B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
WO2011139254A2 (en) * 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical formulations compising cefuroxime axetil

Also Published As

Publication number Publication date
IE33619L (en) 1970-08-17
ES373868A1 (en) 1972-02-16
NL6917696A (en) 1970-08-19
BR6914264D0 (en) 1973-02-22
PL83176B1 (en) 1975-12-31
IL33326A0 (en) 1970-01-29
CS157076B2 (en) 1974-08-23
MY7500052A (en) 1975-12-31
FR2031460A1 (en) 1970-11-20
DE1958329C3 (en) 1974-05-02
US3496171A (en) 1970-02-17
CH531006A (en) 1972-11-30
DE1958329A1 (en) 1970-10-22
FR2031460B1 (en) 1973-04-06
AT293618B (en) 1971-10-25
IE33619B1 (en) 1974-09-04
DE1958329B2 (en) 1973-09-27
IL33326A (en) 1973-02-28
BE742086A (en) 1970-05-25
SE372536B (en) 1974-12-23
GB1254148A (en) 1971-11-17

Similar Documents

Publication Publication Date Title
ZA704887B (en) O-acyl-lysergols and process for preparing them
CA930554A (en) Purification process
CA970784A (en) Purification process
ZA703207B (en) Antibiotic compounds and process for preparing the same
CA942067A (en) Purification process
IL35065A0 (en) New antibiotic and process for preparing same
CA929752A (en) Yttrium purification process
CY784A (en) Process for purifying cephaloglycin antibiotic and the antibiotic thus obtained
CA930958A (en) Purification process
CA929512A (en) 18-cyano-pregnane compounds and process for their manufacture
IL35034A0 (en) New antibiotic and process for preparing same
CA919921A (en) Purification process
CA927611A (en) Purification process
CA921021A (en) Purification process
ZA703916B (en) Nitro-steroids and process for preparing them
CA933756A (en) Purification process
CA850155A (en) Purification process
PH10951A (en) Antibiotic am374 and process for the production thereof
CA820868A (en) Denitrification process
AU438512B2 (en) Purification process
CA829911A (en) Purification process
CA854250A (en) Purification process
CA847932A (en) Purification process
CA848237A (en) Purification process
CA848486A (en) Purification process